CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
Cholecalciferol - CKD +2 moredrug
Likely dose
Cholecalciferol - CKD 50,000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01222234
NCT01222234N/ACompleted
CompareCT.gov

Impact of Vitamin D Therapies on Monocyte Function in Chronic Kidney Disease

University of Kansas Medical Center·interventional·Posted Oct 18, 2010·Updated May 16, 2016

In Brief

A clinical study evaluating Cholecalciferol - CKD, Calcitriol - CKD, and 1 other intervention for Chronic Kidney Disease (CKD) and End-stage Renal Disease (ESRD). Completed, enrolled 56 participants across 1 site.

Detailed Summary

This investigation will consist of a prospective study utilizing two separate populations of patients with 25(OH)D deficiency, one population with chronic kidney disease (CKD) and one with normal renal function.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Disease (CKD), End-stage Renal Disease (ESRD)
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 18, 2010
Enrollment StartOct 1, 2010
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.7 years ago

Interventions

Cholecalciferol - CKDdrug

Cholecalciferol tablet 50,000 IU twice weekly for 8 weeks

Calcitriol - CKDdevice

Calcitriol 0.25 mcg once daily for 8 weeks

Cholecalciferol - non-CKDdrug

Cholecalciferol tablet 50,000 IU twice weekly for 8 weeks